Individualised therapeutic approach to the patient with atypical haemolytic-uraemic syndrome
Atypical haemolytic-uraemic syndrome (aHUS) is a rare disease associated with uncontrolled activation of the alternative complement pathway, leading to thrombotic microangiopathy (TMA). Early diagnosis and treatment with eculizumab, a monoclonal antibody targeting the complement component C5, are cr...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Clinical Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211824054356 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|